Dear Shareholders,
I greet you all to the 20th AGM of Brooks Laboratories Limited.
It's my pleasure to share with you that Brooks Steriscience Limited, Subsidiary of your
Company got its first AN DA approval of injection Meropenem a few days back which makes
this facility at Vadodara a USFDA approved facility. We plan to launch injection Meropenem
in US market by October / November 2022. This shall add lots of strength to your Company.
We are also in process of finalizing our sale agreements of Meropenem in all major
European Countries as we already have got approval of this product in all 30 EU Countries
of Europe including UK.
We also expect more AN DA approvals this year which shall augment immediate business of
the Company.
We shall also be able to commission our API facility of Carbapenems in coming months,
it will resolve all supply chain issues, reducing our dependency on foreign markets for
API & making us much more self- reliant in creating stable business and thus value to
your Company.
On domestic front, last 5 months have seen an unprecedented slump in pharmaceutical
sales, this trend is prevalent post COVID-19 throughout the country including most global
markets, but looks like worst is over and again we started picking up sales in both our
critical care division and in exports. We, also have increased our focus in exports by
initiating registrations in African and LTAM Countries. As we started focusing on these
markets, we are hopeful of getting results in coming years by making us less dependant on
contract manufacturing business in domestic markets. Our focus is nowon our own exports
and on our own domestic marketing of critical care products.
Though USFDA or U KM HRA approvals a re not small steps for any Company, especially in
injectable segment. Our endeavour this year is now to create business volumes in these
markets through our recent approvals in these markets.
Before concluding I once again sincerely thank all our valuable shareholders, our
business partners and all dedicated employees of our Company.
I wish and pray great health & wealth for all reading this message.
| Place: Mumbai |
Atul Ranchal |
| Date: 03.09.2022 |
Chairman |
|
Brooks Laboratories Ltd. |